Item 7.01. Regulation FD Disclosure.

On April 11, 2023, the Company issued a press release announcing the appointment of Annette Marleau, Ph.D. as Chief Scientific Officer of the Company, the text of which is furnished as Exhibit 99.1 and incorporated by reference herein.

The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" with the Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

ITEM 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
99.1            Press Release announcing the appointment of Annette Marleau, Ph.D.
              as Chief Scientific Officer of the Company

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses